Connect with us

Technology

Ultima Genomics Major Sequencing Award for Singapore’s National Precision Medicine (NPM) Program Phase III

Published

on

Marks Ultima’s first major win to support a national-scale clinical whole genome sequencing initiativeNPM Phase III will leverage Ultima’s UG200 Platform and recent advancements that enable large-scale applications, including Solaris 2.0 Chemistry, launched in February 2026.Ultima will partner with Lucence, a leading Singapore-based clinical lab offering clinical and oncology applications, and QIAGEN, the leader in technologies enabling end-to-end clinical sequencing workflows

SINGAPORE and FREMONT, Calif., Nov. 2, 2026 /PRNewswire/ — Ultima Genomics, a company offering a new architecture for enabling ultra-high-throughput next generation sequencing, today announced that its UG200 Sequencing Platform has been selected for the SG-INSIGHT study, a cohort under Phase III of Singapore’s National Precision Medicine (NPM) program, a national initiative focused on advancing the integration of genomics into clinical workflows and healthcare delivery. Precision Health Research, Singapore (PRECISE) is the central coordinating office for the NPM program. The award coincides with recent advancements in Ultima’s technology that enable high-quality, large-scale, and low-cost whole genome sequencing, including the launch of Ultima’s UG200 Sequencing Platform and Solaris 2.0 chemistry in February 2026.  Ultima will support the program through a collaboration with Singapore-based Lucence, a Singapore-based precision medicine leader, and QIAGEN, a global leader in Sample to Insight solutions. 

NPM Phase III significantly expands the scale and scope of Singapore’s precision medicine effort to about 450,000 individuals — nearly one in 10 Singapore residents — with a significant shift toward participants receiving medical treatment and healthcare services. Unlike Phase II, which focused on healthy individuals, Phase III includes patients across a wide spectrum of health conditions from Singapore’s three public healthcare clusters: NHG Health, National University Health System (NUHS) and SingHealth. NPM Phase III is intended to generate evidence to support the safe and effective rollout of genetic screening and future integration of genomics into public healthcare.

The selection of Ultima technology as part of the Consortium led by Lucence follows an extensive evaluation process. Throughout the process, Ultima and its consortium partners demonstrated a comprehensive approach that addressed quality, clinical readiness, pricing and innovation using Ultima’s latest technology, including the UG200 system, Solaris 2.0 chemistry, and bioinformatics analytics.  

“This award is an important milestone for Ultima Genomics and demonstrates significant advancements to our platform that unlock whole genome sequencing for clinical applications at scale, at low cost, and with high-quality data.  NPM Phase III’s SG-INSIGHT cohort is an excellent example of how Ultima’s drive towards lower costs can support national-scale precision medicine initiatives across geographies worldwide.  It also shows how the UG200 can enable our customers and partners to support cost-sensitive initiatives,” said Gilad Almogy, Chief Executive Officer of Ultima Genomics. “We are honored to work alongside Lucence and QIAGEN in Singapore and to contribute to a program that is advancing the integration of genomics into healthcare. NPM Phase III’s SG-INSIGHT represents an important opportunity to demonstrate how innovation, collaboration, and operational excellence can accelerate precision medicine at a population scale.”

Under the collaboration, Lucence will provide end-to-end clinical program management and local operational leadership, QIAGEN will support sample preparation and automation workflows, and Ultima will provide sequencing and genomic analysis capabilities designed to enable high-quality, scalable, clinical-grade whole-genome sequencing. Together, the consortium aims to support the successful execution of NPM Phase III and to establish a model for future national genomics initiatives.

The award further strengthens Ultima’s presence in the Asia-Pacific region and underscores the company’s ongoing commitment to advancing population genomics, precision medicine, oncology, rare disease research, and emerging clinical applications across global healthcare systems. SG-INSIGHT is expected to serve as a key reference program as governments, healthcare providers, and research institutions explore broader adoption of precision medicine.

Singapore has established itself as a global leader in biomedical innovation and precision medicine. Through collaboration with local healthcare, research, and industry partners, Ultima aims to contribute to the development of a sustainable genomics ecosystem that supports scientific advancement, clinical innovation, and long-term healthcare impact.

Ultima continues to advance its sequencing and analysis capabilities to support clinical whole genome sequencing at population scale. These efforts include the recent launch of paired-end sequencing and the development of pangenome-aware WGS analysis, which is expected to be available by year-end 2026. Together, these capabilities will expand the flexibility of Ultima’s technology for whole-genome and other large-scale sequencing applications.

https://www.ultimagenomics.com/

About Ultima Genomics

Ultima Genomics is unleashing the power of genomics at scale. The Company’s mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in human health. With humanity on the cusp of a biological revolution, there is a virtually endless need for more genomic information to address biology’s complexity and dynamic change—and a further need to challenge conventional next-generation sequencing technologies. Ultima’s revolutionary new sequencing architecture drives down the costs of sequencing to help overcome the tradeoffs that scientists and clinicians are forced to make between the breadth, depth and frequency with which they use genomic information. The new sequencing architecture was designed to scale far beyond conventional sequencing technologies, lower the cost of genomic information, and catalyze the next phase of genomics in the 21st century. To learn more, visit www.ultimagenomics.com.

About Precision Health Research, Singapore (PRECISE)

Precision Health Research, Singapore (PRECISE) leads the National Precision Medicine (NPM) programme, advancing genomics to improve health and grow Singapore’s biomedical sector. Phase II sequenced 100,000 Singaporeans, while Phase III, in partnership with Singapore’s three healthcare clusters, is evaluating how genomics can be integrated into clinical care responsibly. 

PRECISE is a programme of the Consortium for Clinical Research and Innovation, Singapore (CRIS). NPM Phase II is supported by the National Research Foundation, Singapore under the White Space funding (MOH-000588 and MOH-001264) and administered by the Singapore Ministry of Health (MOH) through the National Medical Research Council (NMRC) Office, MOH Holdings Pte Ltd. NPM Phase III is supported by the Singapore MOH through the NMRC Office, MOH Holdings Pte Ltd under the NMRC NPM Phase III Funding Initiative (MOH-001734). 

www.npm.sg

Forward-Looking Statements

This press release contains forward-looking statements, including statements regarding anticipated benefits from participation in Singapore’s National Precision Medicine Program, the expected impact of the NPM Phase III initiative, future sequencing volumes and program expansion opportunities, advancement of precision medicine, growth opportunities in Asia-Pacific and other regions, development of future collaborations, and potential clinical and commercial applications of Ultima’s technologies. These forward-looking statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Factors that may affect actual results include program timelines, regulatory developments, market conditions, clinical validation outcomes, operational execution, technological performance, and other risks associated with the commercialization and adoption of genomic technologies. Ultima Genomics undertakes no obligation to update forward-looking statements except as required by applicable law.

mailto:ir@ultimagenomics.com

Media Contact
Vikki Herrera
Oak Street Communications for Ultima Genomics
vikki@oakstreetcommunications.com
408-206-7009

View original content to download multimedia:https://www.prnewswire.com/news-releases/ultima-genomics-major-sequencing-award-for-singapores-national-precision-medicine-npm-program-phase-iii-302926879.html

SOURCE Ultima Genomics

Continue Reading

Technology

Bluehost Brings AI to Life for Small Businesses Worldwide

Published

on

By

From the inaugural ELEVATE Small Business Growth Summit featuring Google, TikTok, Gary Vaynerchuk and Codie Sanchez, to a global AI Builder Tour spanning 10 cities and four continents, Bluehost is bringing together entrepreneurs, technology leaders and AI innovators to turn AI into real business growth.

JACKSONVILLE, Fla., Nov. 5, 2026 /PRNewswire/ — Bluehost, the small business platform for the AI era, today announced a global series of events bringing together entrepreneurs, technology leaders and AI builders to help small businesses move beyond AI hype and put AI to work to build, grow and run their businesses.

The initiative brings together two complementary communities shaping the future of small businesses. On Nov. 10, Bluehost’s inaugural ELEVATE Small Business Growth Summit will help entrepreneurs and small business owners discover practical ways to use AI to build, grow and run their businesses. In parallel, the company’s Small Business AI Builder Tour will connect founders, developers and AI innovators across 10 cities and four continents to showcase new ideas, collaborate with experts and turn AI-powered projects into real-world solutions.

Despite growing awareness of AI, adoption beyond general-purpose chat remains limited. Bluehost’s recent State of Small Business AI Confidence study found that only 16% of surveyed U.S. small business owners had deployed an AI agent. Closing that gap by helping businesses move beyond asking AI questions and transitioning to use AI for marketing, customer discovery, growth and everyday operations is a central focus of Bluehost’s global events and community programs.

“AI is giving small businesses capabilities that once required much larger teams and budgets,” said Sachin Puri, Chief Executive Officer of Newfold Digital, parent company of Bluehost. “But access to AI alone isn’t enough. The real opportunity is helping entrepreneurs put it to work, to build, grow and run their businesses. By bringing together small business owners, technology leaders and AI builders, we’re turning AI’s promise into practical outcomes.”

Bluehost ELEVATE Small Business Growth Summit
Taking place virtually on Nov. 10, 2026, from 12 p.m. to 6 p.m. ET, ELEVATE is a free global summit focused on helping entrepreneurs apply emerging technology to real business challenges. Bluehost will also host local gatherings in San Francisco, Austin and New York, giving small business communities an opportunity to experience the program and connect in person.

Built around three themes, Build, Grow and Run, the program will explore how small businesses can establish and strengthen their digital presence, get discovered and reach more customers, and use AI and automation to operate more effectively.

ELEVATE will feature entrepreneurs and bestselling authors Gary Vaynerchuk, CEO of VaynerMedia, and Codie Sanchez, founder of Contrarian Thinking. Their perspectives on business ownership, marketing and growth reach millions worldwide, and Vaynerchuk’s fireside conversation with Newfold Digital CEO Sachin Puri, will be the summit’s finale.

The lineup also includes Brendan Jacobsen, Global Head of Channel Sales at TikTok; Farhaz Karmali, Product Director at Google; Sachin Puri, CEO of Newfold Digital; Salim Ali, CMO of Bluehost; and Satish Hemachandran, CPO of Bluehost, along with small business owners and additional industry experts.

The ELEVATE Small Business Growth Summit will combine keynotes, conversations, demonstrations and practical guidance that attendees can apply directly to their businesses.

To register for the online event or attend a watch party in New York City, Austin or San Francisco, visit bluehost.com/elevate.

Bluehost AI Builder Tour: Connecting Global AI Communities to Advance Small Business Innovation
Bluehost is bringing together AI builders, developers, founders and engineers across 10 cities and four continents through its Small Business AI Builder Tour, supporting a growing global community of innovators building AI-powered websites, applications, agents and automations.

Partnering with established global AI communities, including AI Tinkerers and AI Camp, Bluehost is collaborating with local builders and community leaders to deliver hands-on experiences that foster knowledge-sharing, collaboration and innovation. Community experts will lead breakout discussions and “Unblock Your Build” sessions, offering participants practical guidance on technical challenges to help advance their projects.

Each event will feature live project showcases, interactive build sessions and expert feedback to help participants take ideas and prototypes closer to launch. The tour also creates opportunities for builders to develop relationships with fellow innovators and the broader AI ecosystem.

The tour kicked off in Florianópolis, Brazil, on Oct. 30, 2026 with additional events scheduled through January 2027.

AI Builder Tour Dates and Locations:

Date                     

City                                         

Venue 

Oct. 30, 2026         

Florianópolis, Brazil            

Square SC

Nov. 5, 2026          

Austin, Texas                      

Distribution Hall

Nov. 17, 2026          

San Francisco, California    

The Avalon

Nov. 18, 2026          

Santiago, Chile                    

Cenco Costanera

Nov. 24, 2026        

Bangalore, India                  

TBD

Nov. 27, 2026          

São Paulo, Brazil                

Cubo Itaú

Dec. 1, 2026          

London, United Kingdom    

Plexal

Dec. 3, 2026          

New York, New York            

TBD

Dec. 11, 2026          

Guadalajara, Mexico            

Tecnológico de Monterrey

Jan. 12, 2027          

Chicago, Illinois                    

TBD

To view upcoming Bluehost Small Business AI Builder Tour locations, learn about planned local programs and register, visit bluehost.com/smb-ai-builder-tour.

About Bluehost
Trusted by over 3 million customers worldwide, Bluehost is the small business platform for the AI era. Bluehost makes it easy for small businesses to build, host, and run online with confidence. From creating sites, stores, logos, apps and campaigns to managing business operations, building and deploying AI agents and apps, Bluehost combines purpose-built AI with high-performance hosting and human expert support available 24/7. Bluehost has been recommended by WordPress.org since 2005. For more information on Bluehost, visit Bluehost.com.

About Newfold Digital
Newfold Digital is a leading web and commerce technology company serving nearly 7 million customers globally through our portfolio of brands including Bluehost, Crazy Domains, HostGator, Network Solutions, Yoast, YITH, and many others. We help customers of all sizes build a digital presence that delivers results. With our extensive product offerings and personalized support, we take pride in collaborating with our customers to serve their online presence needs. Learn more about Newfold Digital at Newfold.com.

Media Contact:
Paola Lorenzo
press@bluehost.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/bluehost-brings-ai-to-life-for-small-businesses-worldwide-302930941.html

SOURCE Bluehost

Continue Reading

Technology

Cashman Preload Cryogenics Selected by Power LNG as LNG Tank Partner for Project Seawolf

Published

on

By

QUINCY, Mass., Nov. 5, 2026 /PRNewswire/ — Power LNG Ventures has selected Cashman Preload Cryogenics (CPC), an affiliate of Jay Cashman, Inc., as its LNG tank partner for Project Seawolf, a marine LNG fueling facility on Pelican Island in Galveston, Texas. CPC will engineer the project’s 3-million-gallon full-containment LNG storage tank through development, permitting and financing.

CPC’s expertise in LNG tank design, permitting and construction reinforces its commitment to project success, safety and excellence

The tank combines a precast, prestressed concrete outer wall with a 9% nickel steel inner tank and a steel dome roof. CPC’s concrete design delivers proven reliability and safety while optimizing cost and schedule. CPC will work with the Project Seawolf team to integrate the tank into the full facility design.

“Power LNG is building critical marine fueling infrastructure at the Port of Galveston,” said Eric Reaman, President & CEO of CPC. “We know what it takes to develop these assets. We’re glad to be on the team at this stage, and we’ll be ready when the project moves to construction.”

Project Seawolf is being developed on approximately 30 acres of port-owned property. Initial production is 400,000 gallons per day, scalable to 800,000 gallons per day as demand grows. The facility will supply LNG to cruise ships and cargo vessels in the Port of Galveston and the Houston Ship Channel, meeting growing demand for lower-emission marine fuel. The project is targeted to enter service by the end of 2028.

“We reviewed the tank technology options for full-containment storage and selected CPC as our tank partner,” said Austin Terry, CEO of Power LNG Ventures. “CPC brings deep experience designing, permitting and building LNG tanks of this size. This selection reflects our commitment to the project, to operational safety and to best-in-class partners.”

About Cashman Preload Cryogenics
Cashman Preload Cryogenics (CPC), part of the Preload International family of companies and an affiliate of Jay Cashman, Inc., designs and builds prestressed concrete tanks for liquid storage. Preload built its first water storage tank in 1930. Since 1952, Preload has designed and built more than 40 low-temperature and cryogenic storage tanks, and many more dike walls, for LNG, LPG, LN/LOX and ammonia. Preload is recognized as the pioneer of circular prestressed concrete liquid storage structures.

About Power LNG Ventures
Power LNG Ventures is a Houston-area developer of small-scale, modular LNG projects. Founded in 2022, the company is developing Project Seawolf, a fully integrated LNG liquefaction, storage, marine bunkering and export facility on Pelican Island at the Port of Galveston. With its strategic partner Énestas, Power LNG is also developing the Harborside Terminal to begin LNG supply by truck while Project Seawolf is built.

View original content:https://www.prnewswire.com/news-releases/cashman-preload-cryogenics-selected-by-power-lng-as-lng-tank-partner-for-project-seawolf-302929803.html

SOURCE Cashman Preload Cryogenics

Continue Reading

Technology

E Tech Group to Present on GMP-Critical Building Management at Automation Fair 2026

Published

on

By

On November 17 and 19, Michael Roy will discuss E Tech Group’s work to modernize a GMP-critical building management control system at a pharmaceutical manufacturing facility in the Greater Boston area utilizing Rockwell’s PlantPAx. E Tech Group will exhibit at Booth #745.

WEST CHESTER, Ohio, Nov. 5, 2026 /PRNewswire/ — E Tech Group, a leading provider of industrial automation and systems integration, 2025 System Integrator of the Year, and Platinum-certified Rockwell Automation Partner, today announced that Michael Roy of E Tech Group will present on modernization of building management systems in GMP-critical environments at Automation Fair 2026 by Rockwell Automation, taking place November 16–19 at the Thomas M. Menino Convention & Exhibition Center in Boston, Massachusetts.

Roy’s Partner Solutions session, “PS21 – Modernizing GMP-Critical Building Management in Pharmaceutical Facilities,” will take place Tuesday, November 17, at 1:00 p.m. ET and Thursday, November 19, at 10:00 a.m. ET in 253C.

The presentation will examine E Tech Group’s work to modernize aging air handler controls across validated production areas at a pharmaceutical manufacturing facility in the Greater Boston area. Because the building management system (BMS) supports GMP-critical environments, the project required careful planning to update the control architecture while maintaining facility operations and meeting stringent reliability, data integrity and compliance requirements.

E Tech Group implemented a fully redundant PlantPAx-based BMS architecture that addressed the immediate modernization need while establishing a scalable framework that could be applied to future system upgrades across the facility. During the session, Roy will discuss the engineering considerations behind the approach, including redundancy, network design, validation and cutover planning, and how the initial implementation established a foundation for subsequent BMS modernization.

“Modernizing a GMP-critical system requires careful planning to protect the conditions the facility depends on every day,” said Roy. “For this project, we wanted to address the immediate need while creating an approach that could be expanded as additional systems are upgraded across the facility.”

Roy is a Principal Engineering Manager at E Tech Group with nearly a decade of experience in automation and electrical engineering. He brings extensive expertise in technical project leadership, business development, and delivering innovative automation solutions.

At Booth #745, attendees can meet with Roy and E Tech Group engineers and life sciences specialists to discuss validated automation, controls modernization and scalable system architectures for regulated manufacturing environments. Visitors can also stop by the booth for a demonstration of SecureOT™, Rockwell Automation’s industrial cybersecurity solution suite, and see how greater visibility into OT assets and network activity can help uncover potential areas of concern and support a more proactive cybersecurity strategy.

E Tech Group supports pharmaceutical, biotechnology and other regulated manufacturers with automation and system integration expertise spanning building management and process control systems, manufacturing execution systems (MES), compliance services and digital transformation. Its engineers help organizations modernize validated systems while addressing integration, reliability and long-term scalability requirements.

For more information about Automation Fair 2026 and to register for the November 16–19 event in Boston, visit the Automation Fair 2026 registration page.

About E Tech Group

E Tech Group is a global CSIA Enterprise Certified automation engineering and system integration firm with locations spanning 8 countries across three continents. Backed by a team of over 900 professionals, the company delivers cutting-edge automation, control, and information solutions to clients in the Life Sciences, Data Centers, Consumer Products, Food & Beverage, and Industrial sectors. In addition to its organic growth, E Tech Group has expanded through several acquisitions, including the most recent additions of E-Volve Systems, Automation Group, and JSat Automation. To learn more, visit E Tech Group’s website, LinkedIn, Facebook, and YouTube.

View original content to download multimedia:https://www.prnewswire.com/news-releases/e-tech-group-to-present-on-gmp-critical-building-management-at-automation-fair-2026-302930310.html

SOURCE E Tech Group

Continue Reading

Trending